Non-Hodgkins Lymphomafind mydrugscancerSingle-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of RituximabChemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate-and High-Grade Non-Hodgkin's Lymphoma
Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab
Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate-and High-Grade Non-Hodgkin's Lymphoma